Dementia drug donepezil has greater benefits for moderate to severe Alzheimers sufferers than for those in the early stages of the disease, researchers from Kings College Londons Institute of Psychiatry have found.
Dementia drug donepezil has greater benefits for moderate to severe Alzheimers sufferers than for those in the early stages of the disease, researchers from Kings College Londons Institute of Psychiatry have found.